FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
Remdesivir impurity LZ-SS, stock10.2g, assay 95.8%, structure like below:
Remdesivir impurity PHG-SSR, stock13.5g, assay 96.2%, structure like below:
Remdesivir impurity RDV-SSR, stock12.4g, assay 95.6%, structure like below:
Remdesivir impurity LZ-SR, stock10.4g, assay 95.9%, structure like below:
Remdesivir impurity PHG-SRR, stock11.8g, assay 96.1%, structure like below:
Remdesivir impurity RDV-SRR, stock11.4g, assay 96.3%, structure like below:
Remdesivir impurity LZF-SS, stock10.4g, assay 96.5%, structure like below:
Remdesivir impurity PHG-SSS, stock12.6g, assay 95.6%, structure like below:
Remdesivir impurity RDV-SSS, stock13.2g, assay 97.1%, structure like below:
Remdesivir impurity LZF-RR, stock12.4g, assay 95.7%, structure like below:
Remdesivir impurity LZF-SR, stock10.2g, assay 96.8%, structure like below:
Remdesivir impurity PHG-SRS, stock10.3g, assay 96.1%, structure like below:
Remdesivir impurity RDV-SRS, stock12.5g, assay 96.6%, structure like below:
Remdesivir impurity LZF-RS, stock12.4g, assay 95.7%, structure like below:
Remdesivir impurity PHG-RSR, stock13.8g, assay 95.6%, structure like below:
Remdesivir impurity RDV-RSR, stock13.8g, assay 95.6%, structure like below:
